Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 9
373
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Activation of the anti-cancer agent upamostat by the mARC enzyme system

, , , , , & show all
Pages 780-784 | Received 14 Nov 2012, Accepted 14 Jan 2013, Published online: 04 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

TF. Plasse, R. Fathi, C. Fehrmann & GA. McComsey. (2023) Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications. Expert Opinion on Investigational Drugs 0:0, pages 1-9.
Read now

Articles from other publishers (28)

Simone Giovannuzzi. 2024. Metalloenzymes. Metalloenzymes 557 580 .
Michel A. Struwe, Axel J. Scheidig & Bernd Clement. (2023) The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target. Journal of Biological Chemistry 299:11, pages 105306.
Crossref
Ylenia Mazzocato, Stefano Perin, Julia Morales-Sanfrutos, Zhanna Romanyuk, Stefano Pluda, Laura Acquasaliente, Giuseppe Borsato, Vincenzo De Filippis, Alessandro Scarso & Alessandro Angelini. (2023) A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue. Bioorganic & Medicinal Chemistry 95, pages 117499.
Crossref
Bernd Clement & Michel A. Struwe. (2023) The History of mARC. Molecules 28:12, pages 4713.
Crossref
Joan Zapiter, Jeffrey R. Harmer, Michel Struwe, Axel Scheidig, Bernd Clement & Paul V. Bernhardt. (2022) Enzyme Electrode Biosensors for N -Hydroxylated Prodrugs Incorporating the Mitochondrial Amidoxime Reducing Component . Analytical Chemistry 94:25, pages 9208-9215.
Crossref
Naveen Vankadari, Vijayasarathy Ketavarapu, Sasikala Mitnala, Ravikanth Vishnubotla, Duvvur Nageshwar Reddy & Debnath Ghosal. (2022) Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics. The Journal of Physical Chemistry Letters, pages 5324-5333.
Crossref
S. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. HopS. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. Hop. 2022. Discovery DMPK Quick Guide. Discovery DMPK Quick Guide 11 61 .
Zhiyi Zhang, Jie Song, Cao Xie, Jun Pan, Weiyue Lu & Min Liu. (2021) Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials. The AAPS Journal 23:2.
Crossref
Patrick Indorf, Christian Kubitza, Axel J. Scheidig, Thomas Kunze & Bernd Clement. (2019) Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates. Journal of Medicinal Chemistry 63:12, pages 6538-6546.
Crossref
Ina Lunk, Felix-Alexander Litty, Sven Hennig, Ingrid R. Vetter, Jürke Kotthaus, Karin S. Altmann, Gudrun Ott, Antje Havemeyer, Carmen Carrillo García, Bernd Clement & Dennis Schade. (2019) Discovery of N -(4-Aminobutyl)- N ′-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 ( h DDAH-1) . Journal of Medicinal Chemistry 63:1, pages 425-432.
Crossref
Sophia Rixen, Antje Havemeyer, Anita Tyl-Bielicka, Kazimiera Pysniak, Marta Gajewska, Maria Kulecka, Jerzy Ostrowski, Michal Mikula & Bernd Clement. (2019) Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism. Journal of Biological Chemistry 294:46, pages 17593-17602.
Crossref
Olivier Berger, Stéphanie Ortial, Sharon Wein, Séverine Denoyelle, Françoise Bressolle, Thierry Durand, Roger Escale, Henri J. Vial & Yen Vo-Hoang. (2019) Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2203-2207.
Crossref
Changmin Park, Joong Gyu Ha, Seungmok Choi, Eunyoung Kim, Keumhan Noh, Beom Soo Shin & Wonku Kang. (2018) HPLC–MS/MS analysis of mesupron and its application to a pharmacokinetic study in rats. Journal of Pharmaceutical and Biomedical Analysis 150, pages 39-42.
Crossref
Luisa B. Maia & José J.G. Moura. 2018. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Angel Llamas, Alejandro Chamizo-Ampudia, Manuel Tejada-Jimenez, Aurora Galvan & Emilio Fernandez. (2017) The molybdenum cofactor enzyme mARC: Moonlighting or promiscuous enzyme?. BioFactors 43:4, pages 486-494.
Crossref
B. Plitzko, A. Havemeyer, B. Bork, F. Bittner, R. Mendel & B. Clement. (2016) Defining the Role of the NADH-Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System. Drug Metabolism and Disposition 44:10, pages 1617-1621.
Crossref
Tamara Mirzapoiazova, Nurbek Mambetsariev, Frances E. Lennon, Bolot Mambetsariev, Joshua E. Berlind, Ravi Salgia & Patrick A. Singleton. (2015) HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression. Frontiers in Oncology 5.
Crossref
Birte Plitzko, Antje Havemeyer, Thomas Kunze & Bernd Clement. (2015) The Pivotal Role of the Mitochondrial Amidoxime Reducing Component 2 in Protecting Human Cells against Apoptotic Effects of the Base Analog N6-Hydroxylaminopurine. Journal of Biological Chemistry 290:16, pages 10126-10135.
Crossref
Luisa B. Maia & José J. G. Moura. (2015) Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases. JBIC Journal of Biological Inorganic Chemistry 20:2, pages 403-433.
Crossref
Gudrun Ott, Antje Havemeyer & Bernd Clement. (2014) The mammalian molybdenum enzymes of mARC. JBIC Journal of Biological Inorganic Chemistry 20:2, pages 265-275.
Crossref
Eva Bauch, Debora Reichmann, Ralf-Rainer Mendel, Florian Bittner, Anne-Marie Manke, Philipp Kurz, Ulrich Girreser, Antje Havemeyer & Bernd Clement. (2015) Electrochemical and mARC-Catalyzed Enzymatic Reduction of para -Substituted Benzamidoximes: Consequences for the Prodrug Concept “Amidoximes instead of Amidines” . ChemMedChem 10:2, pages 360-367.
Crossref
Rami A. Al-Horani & Umesh R. Desai. (2014) Recent Advances on Plasmin Inhibitors for the Treatment of Fibrinolysis-Related Disorders. Medicinal Research Reviews 34:6, pages 1168-1216.
Crossref
Gudrun Ott, Birte Plitzko, Carmen Krischkowski, Debora Reichmann, Florian Bittner, Ralf R. Mendel, Thomas Kunze, Bernd Clement & Antje Havemeyer. (2014) Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC). Chemical Research in Toxicology 27:10, pages 1687-1695.
Crossref
Heyka H. Jakobs, Danilo Froriep, Antje Havemeyer, Ralf R. Mendel, Florian Bittner & Bernd Clement. (2014) The Mitochondrial Amidoxime Reducing Component (mARC): Involvement in Metabolic Reduction of N -Oxides, Oximes and N -Hydroxyamidinohydrazones . ChemMedChem 9:10, pages 2381-2387.
Crossref
Heyka H. Jakobs, Michal Mikula, Antje Havemeyer, Adriana Strzalkowska, Monika Borowa-Chmielak, Artur Dzwonek, Marta Gajewska, Ewa E. Hennig, Jerzy Ostrowski & Bernd Clement. (2014) The N-Reductive System Composed of Mitochondrial Amidoxime Reducing Component (mARC), Cytochrome b5 (CYB5B) and Cytochrome b5 Reductase (CYB5R) Is Regulated by Fasting and High Fat Diet in Mice. PLoS ONE 9:8, pages e105371.
Crossref
Gudrun Ott, Debora Reichmann, Cornelia Boerger, Ingolf Cascorbi, Florian Bittner, Ralf-Rainer Mendel, Thomas Kunze, Bernd Clement & Antje Havemeyer. (2014) Functional Characterization of Protein Variants Encoded by Nonsynonymous Single Nucleotide Polymorphisms in MARC1 and MARC2 in Healthy Caucasians . Drug Metabolism and Disposition 42:4, pages 718-725.
Crossref
Laura Schwarz, Ulrich Girreser & Bernd Clement. (2014) Synthesis and Characterization of para -Substituted N , N′- Dihydroxybenzamidines and Their Derivatives as Model Compounds for a Class of Prodrugs . European Journal of Organic Chemistry 2014:9, pages 1961-1975.
Crossref
Birte Plitzko, Gudrun Ott, Debora Reichmann, Colin J. Henderson, C. Roland Wolf, Ralf Mendel, Florian Bittner, Bernd Clement & Antje Havemeyer. (2013) The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells. Journal of Biological Chemistry 288:28, pages 20228-20237.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.